J&J files for authorization of COVID-19 vaccine booster
Johnson & Johnson (JNJ.N) said on Tuesday it had submitted data to the U.S. Food and Drug Administration for emergency use authorization of a booster shot of its COVID-19 vaccine in people aged 18 years and older. The filing comes after the FDA last week scheduled an Oct. 15 meeting of its expert advisory…